CMG Pharmaceutical Co (XKRX:058820) 5-Year EBITDA Growth Rate : -4.70% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co 5-Year EBITDA Growth Rate?

CMG Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩20.55.

During the past 12 months, CMG Pharmaceutical Co's average EBITDA Per Share Growth Rate was 390.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 47.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of CMG Pharmaceutical Co was 281.30% per year. The lowest was -45.20% per year. And the median was 14.40% per year.

Competitive Comparison of CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

CMG Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CMG Pharmaceutical Co (XKRX:058820) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

CMG Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CMG Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CMG Pharmaceutical Co (XKRX:058820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949

Website

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines